Mostrar el registro sencillo del ítem

dc.contributor.author
Ganzinelli, Sabrina Belen  
dc.contributor.author
Reina, Silvia Lorena  
dc.contributor.author
Matoso, Mirian  
dc.contributor.author
González, Germán Esteban  
dc.contributor.author
Morales, Maria Celina  
dc.contributor.author
Borda, Enri Santiago  
dc.date.available
2018-03-20T18:55:56Z  
dc.date.issued
2014  
dc.identifier.citation
Ganzinelli, Sabrina Belen; Reina, Silvia Lorena; Matoso, Mirian; González, Germán Esteban; Morales, Maria Celina; et al.; PGE2 Generation in Myocardium from Isolated Rat Atrium under Hypoxia and Reoxygenation Conditions. Effect of Anti-â1 IgG from Patients with Chronic Severe Periodontitis; Scientific Research Publishing; Pharmacology & Pharmacy; 5; 2; 2014; 204-215; 43000  
dc.identifier.issn
2157-9431  
dc.identifier.uri
http://hdl.handle.net/11336/39395  
dc.description.abstract
Background: Hypoxia is one of the most frequently encountered stresses in health and disease. Methods: We com-pared the effects of an anti-β1 periodontal IgG (pIgG) and an authentic β1 adrenergic agonist, xamoterol, on iso-lated myocardium from rat atria contractility. We used an ELISA assay to measure the generation of PGE2 in vitro after the addition of either the antibody or the adrenergic agonist. We analyzed the myocardium histopathological-ly in the presence of both the antibody and/or the adrenergic agonist drug during normoxia, hypoxia and reperfu-sion conditions. Results: PGE2 generation increased during the hypoxia and was unchanged during reoxygenation period compared with the production of this prostanoid in atria during normoxia condition. A β1 specific adreno-ceptor antagonist atenolol and the β1 synthetic peptide abrogated the increment of the prostanoid in the presence of pIgG but only atenolol due to it in the presence of xamoterol. The increment of PGE2 was dependent on the activa-tion of cox-1 and cox-2 isoforms. Moreover, cox-2 was more active and produced more increments in the production of PGE2 in the presence of the pIgG than cox-1 activation. Histopathologically, studies of myocardium specimens during these different periods of the experimental protocol: basal (B), hypoxia (H) and reoxygenation (R), were also performed and showed tissue necrosis and edematization at the myocardium level. Conclusion: The phenomenon studied here supports the notion that PGE2 may be responsible for tissue edematization. PGE2 maybe acts as a beneficial modulator in the myocardium and prevents a major injury of it. The inflammation damage to the heart or- gan and cardiomyocytes caused by the actions of the antibodies in the course of heart lesions provoked by cardiovas- cular autoimmune disease, explains some of these results obtained in the present experiments. Further studies will be needed to establish the real role of PGE2 during hypoxia injury of the heart in the course of autoimmune diseases.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Scientific Research Publishing  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Myocardium  
dc.subject
Hypoxia  
dc.subject
Reoxygenation  
dc.subject
Periodontitis  
dc.subject.classification
Medicina Critica y de Emergencia  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
PGE2 Generation in Myocardium from Isolated Rat Atrium under Hypoxia and Reoxygenation Conditions. Effect of Anti-â1 IgG from Patients with Chronic Severe Periodontitis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-03-20T13:15:19Z  
dc.journal.volume
5  
dc.journal.number
2  
dc.journal.pagination
204-215; 43000  
dc.journal.pais
Reino Unido  
dc.description.fil
Fil: Ganzinelli, Sabrina Belen. Universidad de Buenos Aires. Facultad de Odontología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Reina, Silvia Lorena. Universidad de Buenos Aires. Facultad de Odontología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Matoso, Mirian. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: González, Germán Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Universidad de Buenos Aires; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Morales, Maria Celina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Borda, Enri Santiago. Universidad de Buenos Aires. Facultad de Odontología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Universidad de Buenos Aires; Argentina  
dc.journal.title
Pharmacology & Pharmacy  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.4236/pp.2014.52027  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://file.scirp.org/Html/9-2500416_43000.htm